These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 32205176)

  • 21. An individualized prognostic signature and multi‑omics distinction for early stage hepatocellular carcinoma patients with surgical resection.
    Ao L; Song X; Li X; Tong M; Guo Y; Li J; Li H; Cai H; Li M; Guan Q; Yan H; Guo Z
    Oncotarget; 2016 Apr; 7(17):24097-110. PubMed ID: 27006471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrative molecular analysis of metastatic hepatocellular carcinoma.
    Wang D; Zhu Y; Tang J; Lian Q; Luo G; Wen W; Zhang MQ; Wang H; Chen L; Gu J
    BMC Med Genomics; 2019 Nov; 12(1):164. PubMed ID: 31722693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Copy-Number Alteration Burden Differentially Impacts Immune Profiles and Molecular Features of Hepatocellular Carcinoma.
    Bassaganyas L; Pinyol R; Esteban-Fabró R; Torrens L; Torrecilla S; Willoughby CE; Franch-Expósito S; Vila-Casadesús M; Salaverria I; Montal R; Mazzaferro V; Camps J; Sia D; Llovet JM
    Clin Cancer Res; 2020 Dec; 26(23):6350-6361. PubMed ID: 32873569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-cell transcriptomics reveals the landscape of intra-tumoral heterogeneity and stemness-related subpopulations in liver cancer.
    Ho DW; Tsui YM; Sze KM; Chan LK; Cheung TT; Lee E; Sham PC; Tsui SK; Lee TK; Ng IO
    Cancer Lett; 2019 Sep; 459():176-185. PubMed ID: 31195060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single-cell multi-modal chromatin profiles revealing epigenetic regulations of cells in hepatocellular carcinoma.
    Wang C; Huang W; Zhong Y; Zou X; Liu S; Li J; Sun Y; Zhou K; Chen X; Li Z; Wang S; Huang Y; Bai Y; Yin J; Jin X; Liu S; Yuan Y; Deng Q; Jiang M; Liu C; Liu L; Xu X; Wu L
    Clin Transl Med; 2024 Sep; 14(9):e70000. PubMed ID: 39210544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrative Epigenetic Analysis Reveals Therapeutic Targets to the DNA Methyltransferase Inhibitor Guadecitabine (SGI-110) in Hepatocellular Carcinoma.
    Liu M; Zhang L; Li H; Hinoue T; Zhou W; Ohtani H; El-Khoueiry A; Daniels J; O'Connell C; Dorff TB; Lu Q; Weisenberger DJ; Liang G
    Hepatology; 2018 Oct; 68(4):1412-1428. PubMed ID: 29774579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss at 16q22.1 identified as a risk factor for intrahepatic recurrence in hepatocellular carcinoma and screening of differentially expressed genes.
    Chen L; Zhu ZZ; Liu SF; Wan X; Wen BJ; Jiang H; Zhu J; Cong WM
    Neoplasma; 2016; 63(1):114-20. PubMed ID: 26639241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The DNA methylation profile of liver tumors in C3H mice and identification of differentially methylated regions involved in the regulation of tumorigenic genes.
    Matsushita J; Okamura K; Nakabayashi K; Suzuki T; Horibe Y; Kawai T; Sakurai T; Yamashita S; Higami Y; Ichihara G; Hata K; Nohara K
    BMC Cancer; 2018 Mar; 18(1):317. PubMed ID: 29566670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamics of Genomic, Epigenomic, and Transcriptomic Aberrations during Stepwise Hepatocarcinogenesis.
    Jee BA; Choi JH; Rhee H; Yoon S; Kwon SM; Nahm JH; Yoo JE; Jeon Y; Choi GH; Woo HG; Park YN
    Cancer Res; 2019 Nov; 79(21):5500-5512. PubMed ID: 31506333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic copy number alterations with transcriptional deregulation at 6p identify an aggressive HCC phenotype.
    Kwon SM; Kim DS; Won NH; Park SJ; Chwae YJ; Kang HC; Lee SH; Baik EJ; Thorgeirsson SS; Woo HG
    Carcinogenesis; 2013 Jul; 34(7):1543-50. PubMed ID: 23508637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aflatoxin B1 induces persistent epigenomic effects in primary human hepatocytes associated with hepatocellular carcinoma.
    Rieswijk L; Claessen SM; Bekers O; van Herwijnen M; Theunissen DH; Jennen DG; de Kok TM; Kleinjans JC; van Breda SG
    Toxicology; 2016 Mar; 350-352():31-9. PubMed ID: 27153756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The spatial organization of intra-tumour heterogeneity and evolutionary trajectories of metastases in hepatocellular carcinoma.
    Zhai W; Lim TK; Zhang T; Phang ST; Tiang Z; Guan P; Ng MH; Lim JQ; Yao F; Li Z; Ng PY; Yan J; Goh BK; Chung AY; Choo SP; Khor CC; Soon WW; Sung KW; Foo RS; Chow PK
    Nat Commun; 2017 Feb; 8():4565. PubMed ID: 28240289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma.
    Torrecilla S; Sia D; Harrington AN; Zhang Z; Cabellos L; Cornella H; Moeini A; Camprecios G; Leow WQ; Fiel MI; Hao K; Bassaganyas L; Mahajan M; Thung SN; Villanueva A; Florman S; Schwartz ME; Llovet JM
    J Hepatol; 2017 Dec; 67(6):1222-1231. PubMed ID: 28843658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma.
    Wang K; Lim HY; Shi S; Lee J; Deng S; Xie T; Zhu Z; Wang Y; Pocalyko D; Yang WJ; Rejto PA; Mao M; Park CK; Xu J
    Hepatology; 2013 Aug; 58(2):706-17. PubMed ID: 23505090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenome-wide association study in hepatocellular carcinoma: Identification of stochastic epigenetic mutations through an innovative statistical approach.
    Gentilini D; Scala S; Gaudenzi G; Garagnani P; Capri M; Cescon M; Grazi GL; Bacalini MG; Pisoni S; Dicitore A; Circelli L; Santagata S; Izzo F; Di Blasio AM; Persani L; Franceschi C; Vitale G
    Oncotarget; 2017 Jun; 8(26):41890-41902. PubMed ID: 28514750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole-genome sequencing of matched primary and metastatic hepatocellular carcinomas.
    Ouyang L; Lee J; Park CK; Mao M; Shi Y; Gong Z; Zheng H; Li Y; Zhao Y; Wang G; Fu H; Kim J; Lim HY
    BMC Med Genomics; 2014 Jan; 7():2. PubMed ID: 24405831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated analyses of multi-omics reveal global patterns of methylation and hydroxymethylation and screen the tumor suppressive roles of HADHB in colorectal cancer.
    Zhu Y; Lu H; Zhang D; Li M; Sun X; Wan L; Yu D; Tian Y; Jin H; Lin A; Gao F; Lai M
    Clin Epigenetics; 2018; 10():30. PubMed ID: 29507648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Epigenetic Regulation of HCC Metastasis.
    Han TS; Ban HS; Hur K; Cho HS
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of epigenetic aberrations in the development of hepatocellular carcinoma.
    Zhang Y
    Methods Mol Biol; 2015; 1238():709-31. PubMed ID: 25421688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.